4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000102
Director sold 33,750 shares at an average $607.42 ($20,500,518)
- Director acquired 12,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SING GEORGE L · Director
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-25 | Exercise or conversion : show line 1 in the form | +12,750 | $273.67 | $3,489,293 | 97,165 | D |
| 2020-08-25 | Sale : show line 2 in the form | −1,400 | $600.36 | $840,504 | 95,765 | D |
| 2020-08-25 | Sale : show line 3 in the form | −300 | $601.75 | $180,525 | 95,465 | D |
| 2020-08-25 | Sale : show line 4 in the form | −400 | $602.68 | $241,072 | 95,065 | D |
| 2020-08-25 | Sale : show line 5 in the form | −3,000 | $603.53 | $1,810,590 | 92,065 | D |
| 2020-08-25 | Sale : show line 6 in the form | −3,705 | $604.43 | $2,239,413 | 88,360 | D |
| 2020-08-25 | Sale : show line 7 in the form | −4,700 | $605.53 | $2,845,991 | 83,660 | D |
| 2020-08-25 | Sale : show line 8 in the form | −5,168 | $606.43 | $3,134,030 | 78,492 | D |
| Open-market sales · 33,750 sh · avg $607.42 · $20,500,518 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-08-25 | Exercise or conversion : show line 18 in the form Non-Qualified Stock Option (right to buy) | −12,750 | $273.67 | 2024-01-02 | 12,750 | 0 | D |
Loading xslF345X03/edgardoc.xml…